On Tuesday, September 23, 2014, Crescent Point Energy Corp. (“Crescent Point” or the “Company”), one of Canada’s largest light and medium oil producers, closed its recently announced bought deal financing for an offering of 17,290,000 Crescent Point common shares at $43.40 per share to raise gross proceeds of approximately $750 million. The underwriters also exercised in part their over-allotment option to purchase an additional 1,145,000 Crescent Point common shares at the offering price. As a result, a total of 18,435,000 Crescent Point common shares were issued at a price of $43.40 per share for aggregate gross proceeds of approximately $800 million.
The syndicate of underwriters was co-led by BMO Capital Markets and Scotiabank, and included CIBC, RBC Capital Markets, TD Securities Inc., FirstEnergy Capital Corp., National Bank Financial Inc., GMP Securities L.P., Goldman Sachs Canada Inc., Macquarie Capital Markets Canada Ltd., Merrill Lynch Canada Inc., Peters & Co. Limited, Desjardins Securities Inc. and Raymond James Ltd.
The common shares issued under the offering are eligible to receive the dividend for the month of September 2014, which is expected to be paid on October 15, 2014.
Norton Rose Fulbright acted for Crescent Point on all aspects of the public offering. The team was lead by Mark Eade and included Kirsty Sklar, Peter Allegretto, Darren Hueppelsheuser and Robert Joseph (Tax).